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Severe open tibial fractures are limb-threatening injuries. Outcomes depend on a complex 
interplay of patient, injury and treatment factors. 2009 guidelines from the British 
Orthopaedic Association (BOA) and British Association of Plastic, Reconstructive and 
Aesthetic Surgeons (BAPRAS) recommend prophylactic intravenous antibiotic 
administration within three hours of injury. More recent National Institute for Health and 
Care Excellence (NICE) 2016 guidelines recommend pre-hospital antibiotic administration 
where possible. This study aimed to analyse the impact of time to antibiotics on development 
of deep infection. 
 
Methods 
Adult acute Gustilo-Anderson 3B open tibial fractures managed at a single UK Major 
Trauma Centre were reviewed retrospectively over a three-year period, including a period 
before and after the regional ambulance service introduced a policy of administering pre-
hospital intravenous antibiotics to open fractures in 2016. Development of deep infection was 
recorded as the primary outcome measure. Complete case regression analysis was performed. 
Time was assessed as a continuous variable and as thresholds with antibiotics received within 
one or three hours of injury. 
 
Results 
156 patients with 159 fractures were included. Following introduction of new guidance in 
2016, median time to antibiotics decreased from 180 to 160 minutes and more patients 
received pre-hospital antibiotics (2% vs. 33%). Overall, 7.5% developed deep infection 
(n=12) within a median follow-up of 26 months. Logistic regression found no relationship 
 
 
between any independent variable, including time to antibiotic administration, and 
development of deep infection. 
 
Conclusions 
There are a variety of factors identified in the literature and in national policies and treatment 
guidelines as potentially modifiable to reduce the risk of deep infection following open 
fractures. In this study, time to antibiotic administration was not associated with the risk of 
developing deep infection. The results of this study demonstrate a low infection rate, which 
may be due to expedient expert care delivered by a dedicated orthoplastic service in line with 




Severe open tibial fractures are limb-threatening injuries. Contemporary treatment strategies 
have drastically improved outcomes, meaning limb salvage is now not only possible, it is the 
standard of care. Despite this, reported deep infection rates vary widely: recent series report 
rates between 5 – 20%, even in specialist centres1-5. Deep infection can lead to hospital 
readmission, further surgery, and amputation, which can adversely affect rehabilitation and 
overall outcome and lead to an increased health economic burden6. 
 
The current ‘gold standard’ approach to such injuries involves a joint ‘orthoplastic’ approach 
with expedient antibiotic delivery, surgical wound excision, and definitive bony fixation and 
soft tissue coverage within the first few days following injury. National United Kingdom 
(UK) guidance issued jointly in 2009 by the British Orthopaedic Association (BOA) and 
British Association for Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) 
recommends prophylactic intravenous antibiotic administration within three hours of injury7. 
Updated guidance issued by the UK National Institute for Health and Care Excellence 
(NICE) in 2016 recommends antibiotic delivery within the first hour post injury (that is, pre-
hospital) where possible, and the newest BOA Standard for Trauma on this topic (BOAST4) 
has been updated in accordance with this8,9.  
 
The evidence supporting an association between the timing of delivery of antibiotics with the 
risk of deep infection is mixed. Patzakis and Wilkins found infection rates were nearly twice 
as high in patients receiving antibiotics more than three hours post injury3. Lack and 
colleagues found deep infection was approximately three times more frequent if antibiotics 
were delivered between 60- and 90-minutes post injury compared to if they were delivered 
within 60 minutes2. However, a 2013 study found no difference in non-union or deep 
 
 
infection rates in those patients receiving intravenous antibiotics by HEMS crews pre-
hospital10, and a recent systematic review found no robust evidence of an association, with all 
published studies being at high risk of bias, and recommended further evidence was 
established before policy changes were instigated11.   
 
Existing evidence is largely derived from small, heterogenous cohorts, making it difficult to 
draw meaningful conclusions to guide clinical practice. A number of the published studies 
are old and not reflective of contemporary practice. This study aimed to analyse the impact of 
time to antibiotics on development of deep infection in severe open tibial fractures managed 
in a specialist orthoplastic setting in the UK. 
 
Methods 
Adult acute Gustilo-Anderson 3B open tibial fractures managed between 2015 and 2018 at a 
single UK Major Trauma Centre were reviewed retrospectively. Patients undergoing initial 
emergency management at a district general hospital and transferred for definitive 
management to the Major Trauma Centre were included. Patients were followed up for a 
minimum of one year in line with the Getting it Right First Time definition of deep incisional 
infection in the presence of an implant12. These guidelines relate to infections in the elective 
setting, but have been used in the absence of an accepted minimum follow-up period in the 
trauma setting.  
 





Development of deep infection was recorded as the primary outcome measure. Deep 
infection was defined as clinical presentation with infected non-union of the tibia, delayed 
(partial) flap failure due to infection, deep infected collection requiring return to theatre, 
and/or removal of metalwork due to infection. All infections were confirmed by positive 
direct or enrichment culture of deep tissue samples. 
 
The regional ambulance service introduced a policy enabling paramedics to administer pre-
hospital intravenous antibiotics in 2016.  
 
Statistical analyses were performed using GraphPad Prism (version 8.0.2, GraphPad Software 
Inc., San Diego, USA). Continuous data was checked for normality with a D’Agostino and 
Pearson test. None of the data was normally distributed and therefore central tendency was 
described with the median and interquartile range. 
 
A complete case multiple regression analysis was conducted to determine which factors 
influenced the risk of deep infection (dependent variable). Seven cases were excluded from 
the analysis due to missing data (see Fig. 1). Independent variables included in the final 
multiple regression model were gender, age, follow-up time (months), primary or secondary 
transfer, ISS, unilateral or bilateral fracture, injury mechanism causing gross contamination 
(i.e. marine-, farmyard- or sewage-related injuries), presence of at least one relevant 
comorbidity (diabetes mellitus, peripheral vascular disease, current smoking status, and/or 
immunosuppression), type of antibiotic, time from injury to first antibiotic dose, time from 
injury to first debridement and time from injury to definitive coverage. Time was assessed as 





Multicollinearity was assessed and addressed where it was a problem (R2>0.75); it was 
addressed either by grouping variables or removal of variables from the model (e.g. type of 
antibiotic) until it was no longer a problem. 
 
Results 
159 grade 3B open fractures in 156 patients between October 2015 and June 2018 met the 
inclusion criteria (Fig. 1). The male:female ratio was 1.2:1. The median age at injury was 51 
years (interquartile range (IQR) 31 to 71). The median follow-up was 26 months (IQR 18 to 
39). The majority of patients (n=93, 60%) were primary transfers from the site of injury to 
the Major Trauma Centre (MTC); the remainder were received at peripheral trauma units and 
transferred to the MTC within 48 hours. Some underwent initial surgical wound excision and 
temporary stabilisation at the referring trauma unit. The median ISS was 9 (IQR 9 to 9, 
minimum 4, maximum 57).  
 
The median time to the first dose of antibiotic post injury was 162 minutes (IQR 120 to 207). 
Overall, 21% of patients (n=33) received antibiotics prehospital. Forty-five percent (n=72) 
received co-amoxiclav, especially those receiving antibiotics pre-hospital and those 
transferred in from district general hospitals. Thirty-five percent (n=56) received a 
combination of flucoxacillin and gentamicin, which is the recommended first line 
prophylaxis at the studied centre. The median time to first surgical wound excision was 19 
hours (IQR 14 hours 19 minutes to 23 hours 40 minutes). The median time to definitive soft 




Twelve deep infections as defined above (7.5% of fractures) were recorded (Table 1). The 
multiple regression model (Table 2) showed that whether a patient received their first dose of 
antibiotics prehospital (p=0.963), the time to delivery of the first dose of antibiotic (as a 
continuous variable) (p=0.431), whether antibiotics were delivered within one hour (p=0.099) 
or three hours (p=0.848) of injury, the time to first surgical wound excision (as a continuous 
variable) (p=0.182) and the time to definitive soft tissue coverage (p=0.414) were not 
associated with the development of deep infection. 
 
Following introduction of new guidance in 2016, median time to antibiotics decreased from 
180 to 160 minutes and more patients received pre-hospital antibiotics (2% vs. 33%). The 




This study found that within a specialist orthoplastic setting, where severe open tibial 
fractures are managed expediently by a dedicated service largely in accordance with national 
best practice, there was no correlation between timing of administration of intravenous 
antibiotics and deep infection, and, indeed, no other independent variable was found to be 
associated with the development of deep infection in this cohort of patients.  
 
The number of patients receiving pre-hospital antibiotics did increase following introduction 
of new guidance and the infection rate did fall; however, this was not statistically significant.   
 
Two thirds of patients (67%) did not receive pre-hospital antibiotics, indicating either that the 
guidelines proved difficult to comply with in our region or that it is taking time for the 
 
 
change in policy to result in a change in practice. The reasons for this are not clear, but may 
relate to the study period falling within the early phase following introduction of new 
guidelines and the time needed to train healthcare personnel and provide resources to deliver 
the new treatment policy, particularly given the costs involved. 
 
In a healthcare service operating with finite resources, national recommendations must focus 
on high impact interventions with a robust evidence base. The cost associated with training 
paramedics to recognise open fractures, administer intravenous antibiotics for this indication 
and providing paramedic crews to attend all patients with a possible diagnosis of an open 
fracture must be weighed against any potential return in gains in the form of reduced 
infection rate. 
 
The clinical outcome in patients with severe open tibial fractures is influenced by a complex 
interplay between patient, injury and treatment factors. Many elements of care governed by 
national guidance are not supported by unequivocal clinical evidence: time to initial surgical 
debridement and wound excision has been shown by some studies to be associated with 
increased risk of deep infection13 but others have shown no association1,4. Similarly, use of 
negative pressure wound therapy to temporise open fractures, which is recommended by 
national societies (BOA, BAPRAS) and routinely used by many specialist centres, has 
recently been shown to have no impact on long term outcome in a randomised controlled trial 
of open lower limb fractures14. 
 
Similarly, some studies support administration of antibiotics within one hour of injury2, while 
others have shown that pre-hospital administration of antibiotics does not impact on deep 
infection or non-union rates10. A large, albeit heterogenous, Canadian cohort study found no 
 
 
association between time to antibiotics and development of deep infection15,16. A recent 
systematic review on the topic did not find enough robust evidence to support administration 
of pre-hospital antibiotics11, findings supported by the results of this paper.  
 
It is difficult to glean meaningful conclusions to guide clinical practice from the available 
evidence as many studies are outdated or performed outside of the UK, where the treatment 
framework may significantly differ. However, the findings of the United States-based LEAP 
group, showing time to arrival at a specialist centre to be the only significant factor impacting 
on deep infection, seem at least logical given the complexity of these injuries. The infection 
rate reported here is lower than most other comparable studies, and this may be a result of 
expedient, high quality care delivered by pre-hospital and emergency practitioners and by a 
dedicated, expert joint orthoplastic service in accordance with national guidance where 
achievable. 
 
Strengths and limitations 
This is one of the largest UK cohorts of Gustilo-Anderson grade 3B open tibial fractures to 
be reported in the literature. However, it is a retrospective, single-centre study. The primary 
outcome measure, deep infection, is a relatively rare event in this cohort, making analysis by 
logistic regression difficult to interpret. No power calculations were undertaken a priori, but 
post hoc power calculations (achieved power of 0.9 from calculated effect size, assuming a 
two-tail test) suggest the sample size was large enough to detect a difference if one was 
present. The complex nature of these injuries and their management mean that randomised 
controlled trials are required to better guide clinical practice rather than further, larger 
observational studies. We propose a randomised controlled trial to compare the impact on 
 
 
deep infection rates of immediate, pre-hospital administration of antibiotics (within one hour 
of injury) vs. the early, in-hospital administration of antibiotics (within three hours of injury). 
 
Conclusion 
There is no consensus in the existing literature as to which element of care impacts the most 
on development of deep infection in severe open tibial fractures, and therefore which element 
should be emphasised in national guidance and supported by prioritisation of funding and 
resources. Our centre has a low infection rate, which may be due to expedient, expert care 
delivered by a dedicated orthoplastic service in line with national guidance where achievable. 
The vital next step in better understanding these complex and life-changing injuries is to 
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Figure 1: Flow diagram of excluded patients 
 
Total records identified (n=176) 
Excluded  (n= 17) 
- Initial injury/management abroad (n= 3) 
- Delayed presentation >48h (n= 2) 
- Loss to follow-up at less than 12 months 
(n=1) 
- Death (any cause) prior to 12 months 
follow-up (n=9) 




Dataset included in regressions 
(n=152) 
Included fractures (n=159) 




Table 1: Details of deep infections. (PMH, past medical history; MTC, Major Trauma Centre; DM, Diabetes Mellitus; PVD, peripheral vascular 
disease; ALT, anterolateral thigh; ROMW, removal of metalwork; BKA, below knee amputation; AKA, above knee amputation; Staph., 
staphylococcus; Strep., streptococcus; E., escherichia) 



















29 Smoker Primary Flucloxacillin 
+ gentamicin 














9 Smoker Primary Flucloxacillin 
+ gentamicin 
182 4 Direct closure ROMW, 2-stage 
debridement, free ALT 
reconstruction 
Beta haemolytic 
group G strep. 
44 
 
9 DM Secondary Gentamicin + 
teicoplanin 
153 10 Local fasciocutaneous 
flap 
2-stage debridement, 






13 None Primary Co-amoxiclav 155 14 Free scapular/ 
parascapular flap 
2-stage debridement, 
ROMW, failed salvage free 
ALT flap, subsequent 
successful medial 







9 None Secondary Co-amoxiclav 105 3 Free ALT flap Exchange metalwork, 









250 54 Free ALT flap Debridement, ROMW; 
subsequent infection 














325 2 Local fasciocutaneous 
flap 







9 None Primary Gentamicin + 
teicoplanin 






9 None Primary Co-amoxiclav 80 18 Medial + lateral 
gastrocnemius flap + 
peroneus brevis flap 
AKA for osteomyelitis No deep samples 





25 None Secondary Co-amoxiclav 385 19 Medial gastrocnemius 
flap 





9 None Primary Co-amoxiclav 74 33 Free ALT flap Debridement, sampling, 













t value p value 
Gender  -0.0610 -0.1708 to 0.0487 1.100 0.273 
Age -0.0007 -0.0034 to 0.0019 0.536 0.593 
Follow up (months) 0.0021 -0.0028 to 0.0071 0.848 0.398 
Primary or 
secondary transfer -0.0671 -0.1721 to 0.0379 1.264 0.209 
ISS 0.0005 -0.0059 to 0.0070 0.168 0.867 
Diabetes 0.1430 -0.0583 to 0.3443 1.406 0.162 
PVD -0.0495 -0.2366 to 0.1375 0.524 0.601 
Smoker 0.0226 -0.1040 to 0.1492 0.353 0.725 
Immunocompromise -0.0110 -0.1355 to 0.1138 0.172 0.864 
Unilateral or 
bilateral fracture -0.0468 -0.2881 to 0.1946 0.383 0.702 
Contamination with 
marine, farmyard or 
sewage waste -0.0728 -0.4814 to 0.3358 0.353 0.725 
Antibiotic received 
pre-hospital -0.0036 -0.1547 to 0.1476 0.047 0.963 
Time from injury to 
first dose of 
antibiotic -0.0003 -0.0010 to 0.0004 0.791 0.431 
Time from injury to 
first debridement 0.0047 -0.0022 to 0.0117 1.343 0.182 
Time from injury to 
definitive coverage -0.0004 -0.0015 to 0.0006 0.819 0.414 
Antibiotics received 
within 1 hour of 
injury 0.1906 -0.0363 to 0.4175 1.663 0.099 
Antibiotics received 
within 3 hours of 
injury -0.0105 -0.1188 to 0.0978 0.192 0.848 
 
 
